Xiaojun Xia, Ph.D. - Publications

2007 The University of Texas Graduate School of Biomedical Sciences at Houston 
Molecular Biology, Cell Biology

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Shen H, Mu C, Wu X, Zhou X, Wolfram J, Shen J, Zhang D, Mai J, Xia X, Holder AM, Ferrari M, Liu X. Chemotherapy sensitizes therapy-resistant cells to mild hyperthermia by suppressing heat shock protein 27 expression in triple negative breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29921732 DOI: 10.1158/1078-0432.CCR-17-3872  0.48
2018 Wang F, Xia X, Yang C, Shen J, Mai J, Kim HC, Kirui D, Kang Y, Fleming JB, Koay EJ, Mitra S, Ferrari M, Shen H. SMAD4 gene mutation renders pancreatic cancer resistance to radiotherapy through promotion of autophagy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29602802 DOI: 10.1158/1078-0432.CCR-17-3435  0.48
2016 Mu C, Wu X, Ma H, Tao W, Zhang G, Xia X, Shen J, Mai J, Sun T, Sun X, Arlinghaus RB, Shen H. Effective concentration of a multi-kinase inhibitor within bone marrow correlates with in vitro cell killing in therapy-resistant chronic myeloid leukemia. Molecular Cancer Therapeutics. PMID 26846820 DOI: 10.1158/1535-7163.MCT-15-0577-T  0.48
2015 Xia X, Mai J, Xu R, Perez JE, Guevara ML, Shen Q, Mu C, Tung HY, Corry DB, Evans SE, Liu X, Ferrari M, Zhang Z, Li XC, Wang RF, et al. Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon response. Cell Reports. 11: 957-66. PMID 25937283 DOI: 10.1016/j.celrep.2015.04.009  0.48
2014 Mai J, Huang Y, Mu C, Zhang G, Xu R, Guo X, Xia X, Volk DE, Lokesh GL, Thiviyanathan V, Gorenstein DG, Liu X, Ferrari M, Shen H. Bone marrow endothelium-targeted therapeutics for metastatic breast cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. 187: 22-9. PMID 24818768 DOI: 10.1016/j.jconrel.2014.04.057  0.48
2014 Zhang M, Xu R, Xia X, Yang Y, Gu J, Qin G, Liu X, Ferrari M, Shen H. Polycation-functionalized nanoporous silicon particles for gene silencing on breast cancer cells. Biomaterials. 35: 423-31. PMID 24103653 DOI: 10.1016/j.biomaterials.2013.09.033  0.48
2013 Xia X, Liu S, Xiao Z, Zhu F, Song NY, Zhou M, Liu B, Shen J, Nagashima K, Veenstra TD, Burkett S, Datla M, Willette-Brown J, Shen H, Hu Y. An IKKα-nucleophosmin axis utilizes inflammatory signaling to promote genome integrity. Cell Reports. 5: 1243-55. PMID 24290756 DOI: 10.1016/j.celrep.2013.10.046  0.48
2013 Shen J, Xu R, Mai J, Kim HC, Guo X, Qin G, Yang Y, Wolfram J, Mu C, Xia X, Gu J, Liu X, Mao ZW, Ferrari M, Shen H. High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics. Acs Nano. 7: 9867-80. PMID 24131405 DOI: 10.1021/nn4035316  0.48
2013 Xu R, Huang Y, Mai J, Zhang G, Guo X, Xia X, Koay EJ, Qin G, Erm DR, Li Q, Liu X, Ferrari M, Shen H. Multistage vectored siRNA targeting ataxia-telangiectasia mutated for breast cancer therapy. Small (Weinheim An Der Bergstrasse, Germany). 9: 1799-808. PMID 23293085 DOI: 10.1002/smll.201201510  0.48
2013 Fan J, Huang Y, Finoulst I, Wu HJ, Deng Z, Xu R, Xia X, Ferrari M, Shen H, Hu Y. Serum peptidomic biomarkers for pulmonary metastatic melanoma identified by means of a nanopore-based assay. Cancer Letters. 334: 202-10. PMID 23200677 DOI: 10.1016/j.canlet.2012.11.011  0.48
Show low-probability matches.